SPON2 is associated with cellular adhesion,[16] whereas THBS1 is involved in angiogenic and tumorigenic activity such that it is frequently mutated in the context of cancer progression.[17] Heterozygous THSD7B variants can result in decreases in cellular adhesion together with enhanced tumor cell invasivity and metastasis. The gene discussed is SPON2; the disease is cancer.